US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Ceres Inc (PK) (CEEIF) 銘柄情報

Ceres Inc (PK) (CEEIF)

23.13

0.00

(0.00%)

終了 6月11日 5:00AM

Ceres Inc (PK) (CEEIF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

23.13

( - )

買値

10.08

売値

12.12

出来高

-

0.00 日の範囲 0.00

12.9007 52 週間の範囲 23.13

時価総額

前日終値

23.13

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 189,510

発行済株式数

11,819,612

配当利回り

60 (3.13%)

PER

5.82

1 株当たり利益 (EPS)

307.53

歳入

31.5B

純利益

3.55B

Ceres Inc. offers mobile and financial services in Japan and internationally. It offers its services through Points, where the company operates Moppy that is a service giving points to exchange for cash or electronic money; AD.TRACK, an ASP that connects advertisements related to advertisers product... Ceres Inc. offers mobile and financial services in Japan and internationally. It offers its services through Points, where the company operates Moppy that is a service giving points to exchange for cash or electronic money; AD.TRACK, an ASP that connects advertisements related to advertisers products and services with affiliate media; D2C business for developing, manufacturing, and selling products in-house; and DX business for supporting business, business transformation, and customer contact point reform. The company also provides blockchain, online factoring, and investment development business services. Ceres Inc. was incorporated in 2005 and is based in Setagaya, Japan. 詳細を表示

セクター

Industrials

業界

Industrial Conglomerates

ウェブサイト

ceres-inc.jp

本社

Setagaya, Japan

設立

2026

Ceres Inc (PK) is listed in the Industrials sector of the その他OTC with ticker CEEIF. The last closing price for Ceres (PK) was US$23.13. Over the last year, Ceres (PK) shares have traded in a share price range of US$ 12.9007 to US$ 23.13.

Ceres (PK) currently has 11,819,612 shares in issue. The market capitalisation of Ceres (PK) is US$273.39 million. Ceres (PK) has a price to earnings ratio (PE ratio) of 5.82.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	23.13	23.13	23.13	0	0	CS
26	0	0	23.13	23.13	12.9007	25	12.9007	CS
52	6.1516	36.231918202	16.9784	23.13	12.9007	25	17.80796	CS
156	17.0404	279.827903311	6.0896	24.08	5.671	63	14.98955833	CS
260	-6.9724	-23.1622727756	30.1024	30.1024	0.0025	78	16.84314521	CS

CEEIF - Frequently Asked Questions (FAQ)

What is the current Ceres Inc (PK) share price?

The current share price of Ceres Inc (PK) is US$ 23.13

How many Ceres Inc (PK) shares are in issue?

Ceres Inc (PK) has 11,819,612 shares in issue

What is the market cap of Ceres Inc (PK)?

The market capitalisation of Ceres Inc (PK) is USD 273.39M

What is the 1 year trading range for Ceres Inc (PK) share price?

Ceres Inc (PK) has traded in the range of US$ 12.9007 to US$ 23.13 during the past year

What is the PE ratio of Ceres Inc (PK)?

The price to earnings ratio of Ceres Inc (PK) is 5.82

What is the cash to sales ratio of Ceres Inc (PK)?

The cash to sales ratio of Ceres Inc (PK) is 0.67

What is the registered address of Ceres Inc (PK)?

The registered address for Ceres Inc (PK) is Shibuya Sakura Stage SHIBUYA Tower, Setagaya, Tokyo, 1506221

What is the Ceres Inc (PK) website address?

The website address for Ceres Inc (PK) is ceres-inc.jp

Which industry sector does Ceres Inc (PK) operate in?

Ceres Inc (PK) operates in the Industrial Conglomerates sector

fink

I’m keeping my focus on Argentina Gold mines. Newmont, but specifically FSM due to the price drop. I think South America will lead the world. Less drama too.

I can’t lose my grip on my LNG to load the boat. Gold takes time.

Trooperstocks

Trooperstocks 15秒前

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

Trooperstocks

Trooperstocks 20秒前

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

AveragePenny

AveragePenny 37秒前

PTOP Secures Largest Enterprise Opportunity in Company History With BostonApartments.com(R) - Here is How It Will Operate

https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/ptop-secures-largest-enterprise-opportunity-in-company-history-wi-1174872

Sammy boy

Sammy boy 41秒前

Every time Trump mentions the evaluation now we drop, very similar to Pulte’s TV appearance’s.

Getting crazier by the day !

Trooperstocks

Trooperstocks 44秒前

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

Trooperstocks

Trooperstocks 49秒前

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

Lite

Wouldn’t re-listing the GSEs greatly enhance transparency of share trading? Why does this Administration not work towards transparency?

EnchantedPirate5

EnchantedPirate5 2分前

agq
buying AGQ on the open.

DOGONE

Good interview. https://podcasts.apple.com/us/podcast/interview-on-amfn-with-executive-chairman-of/id1459370287?i=1000771261150

pennybiteme

pennybiteme 3分前

I was there but you were not just saying.

getmoreshares

getmoreshares 3分前

🌐UNCHANGED OUTSTANDING SHARES 6/10/26

Outstanding Shares 160,236,914 03/11/2026
Restricted 101,420 03/11/2026
Unrestricted 160,135,494 03/11/2026
Held at DTC 160,135,494 03/11/2026
Authorized Share 500,000,000 03/11/2026

docj

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease
Download as PDFJune 11, 2026 8:30am EDT
Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the

big bopper1

big bopper1 3分前

cydy with cornell uniersity will use our drug to do phase 2 study on alzheimer disease.

prototype_101

prototype_101 4分前

LWLG Polymers will solve NVIDIA's MRR (micro-ring resonator modulators) issues!!

Reducing Power Consumption and the Need for Heater ICs: NVIDIA's MRR technology, while highly compact, is susceptible to thermal drift. This means that as the temperature changes, the resonant frequency o

DeadCellShadix

DeadCellShadix 4分前

PPCB Buyback News:

Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced it has approved a share repurchase program authori

AlwaysRed

AlwaysRed 4分前

They certainly have been pounding the price the last 4 days:

https://www.cmegroup.com/markets/metals/precious/silver.volume.html

Griff35

Griff35 4分前

getmoreshares

getmoreshares 5分前

had the same downgrade happen to a different position- OTC error.

CatfishHunter

CatfishHunter 5分前

https://x.com/vivosincusa/status/2065050253129331078?s=46&t=MFPDnhLdbuc8M9UmbDfCTw

TheRealSarsoor

TheRealSarsoor 5分前

https://www.linkedin.com/posts/diesel-marketing_investor-presentation-activity-7470787948720869377-PtAR?utm_source=share&utm_medium=member_android&rcm=ACoAAAFYb90BO4fY8BCiB31JXid7ZGW_VhVEiac
Sparc and $HGRAF is official. Putting us in there next to some big names.

mike_dotcom

mike_dotcom 5分前

Another new 52 week low coming? It seems inevitable.

fricassee

fricassee 6分前

Where else can a revolutionary new material go but up?

axelvento

axelvento 6分前

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer

https://ir.immuneering.com/news-releases/news-release-details/immuneering-announces-first-patient-dosed-pivotal-phase-3

trader_ron

trader_ron 6分前

$ARTM News- American Nortel Provides India Operations Update: Technology Infrastructure and Data Systems Positioned to Support Continued Sales Growth
https://www.otcmarkets.com/stock/ARTM/news/American-Nortel-Provides-India-Operations-Update-Technology-Infrastructure-and-Data-Systems-Position

Jpm Rmb Us Etfa

Petro Matad (PK)

Essential Properties Rea...

Amundi EUR Corporate Bon...

Unity Wealth Partners Dy...

SSGA SPDR ETFs Europe II... (ID)

VanEck ETF Trust VanEck ...

Intergrated Media Techno...

Renaissance Us Growth Invst

Empr Dis Y Com N B Adr20/

Leveraged DAX X4 Kursindex

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。